(PharmaNewsWire.Com, February 26, 2018 ) The global amniocentesis needle market is expected to reach USD 172.8 Million by 2022 from USD 150.6 Million in 2017, at a CAGR of 2.8%. The high reliability of the amniocentesis technique, rise in the median age of first-time motherhood, and increasing burden of congenital disorders are key factors driving the growth of this market.
The global amniocentesis needle market is segmented by type, procedure, end user, and regions. By type, the amniocentesis needles market is segmented into needles of length 100–150 mm, larger than 150 mm, and smaller than 100 mm. The 100–150 mm segment is estimated to account for the largest market share of the global amniocentesis needle market in 2017. Factors driving the growth of this segment include the widespread use of these needles on account of their optimal length and suitability of use for most patients.
By procedure, the market is classified into amniocentesis, amnioreduction, fetal blood transfusion, amnioinfusion, and cordocentesis. The amniocentesis segment is estimated to account for the largest share of the global amniocentesis needle market during the next five years. High reliability of the amniocentesis technique and the extensive use of this procedure to diagnose the abnormalities in the developing fetus are driving the growth of this market.
On the basis of end user, the amniocentesis needle market is segmented into hospitals, diagnostic centers, clinics, and other end users. The hospitals segment is estimated to account for the largest share of the global market during the forecast period. Growth in the number of hospitals coupled with better accessibility and availability of test results in hospitals are major factors driving the growth of this end-user segment.
The global amniocentesis needle market is dominated by North America, followed by Europe. North America will continue to dominate the global market during the forecast period. Factors such as the rising government initiatives and increasing healthcare expenditure are driving the growth of the market in this region.
The availability of alternate methods for prenatal diagnosis may restrain market growth to a certain extent.
Major industry players acquired companies and business units from other companies to maintain and improve their position in the amniocentesis needle market. Medtronic (Ireland), BD (US), CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US), Medline (US), and Cook Medical (US) have been identified as the key players in this market. These companies have a broad product portfolio with comprehensive features. These leaders have products for all end users in this market, and have a strong geographical presence.
About Us: Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
